Effect of Sildenafil on Pulmonary Artery Pressure, Systemic Pressure, and Nitric Oxide Utilization in Patients With Left Ventricular Assist Devices

Annals of Thoracic Surgery

Volumn 83, Issue 1, 2007, Pages 68-71

  Klodell Jr , Charles T ^a   Morey, Timothy E ^a   Lobato, Emilio B ^a   Aranda Jr , Juan M ^a   Staples, Edward D ^a   Schofield, Richard S ^a   Hess, Philip J ^a   Martin, Tomas D ^a   Beaver, Thomas M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOBUTAMINE; MILRINONE; NITRIC OXIDE; SILDENAFIL; VASOPRESSIN;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DRUG EFFECT; DRUG UTILIZATION; FEMALE; HEART ASSIST DEVICE; HEART RATE; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; MALE; MEAN ARTERIAL PRESSURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REBOUND; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; WEANING;

ADMINISTRATION, INHALATION; ADULT; AGED; BLOOD PRESSURE; FEMALE; HEART-ASSIST DEVICES; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NITRIC OXIDE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PULMONARY ARTERY;

EID: 33845492632     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.08.051     Document Type: Article

References (19)

1. Khazin V., Kaufman Y., Zabeeda D., et al. Milrinone and nitric oxide: combined effect on pulmonary artery pressures after cardiopulmonary bypass in children. J Cardiothorac Vasc Anesth 18 (2004) 156-159
2. Thelitz S., Oishi P., Sanchez L.S., et al. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs. Pediatr Crit Care Med 5 (2004) 234-239
3. Oishi P., Grobe A., Benavidez E., et al. Inhaled nitric oxide induced NOS inhibition and rebound pulmonary hypertension: a role for superoxide and peroxynitrite in the intact lamb. Am J Physiol Lung Cell Mol Physiol 290 (2006) L359-L366
4. Abrams D., Schulze-Neick I., and Magee A.G. Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84 (2000) E4
5. Prasad S., Wilkinson J., and Gatzoulis M.A. Sildenafil in primary pulmonary hypertension. N Engl J Med 343 (2000) 1342
6. Schumacher Y.O., Zdebik A., Huonker M., and Kreisel W. Sildenafil in HIV-related pulmonary hypertension. AIDS 15 (2001) 1747-1748
7. Stiebellehner L., Petkov V., Vonbank K., et al. Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension. Chest 123 (2003) 1293-1295
8. Weimann J., Ullrich R., Hromi J., et al. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiology 92 (2000) 1702-1712
9. Lepore J.J., Maroo A., Pereira N.L., et al. Effect of sildenafil on the acute pulmonary vasodilator response to inhaled nitric oxide in adults with primary pulmonary hypertension. Am J Cardiol 90 (2002) 677-680
10. Ghofrani H.A., Olschewski H., Seeger W., and Grimminger F. [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure]. Pneumologie 56 (2002) 665-672
11. Ghofrani H.A., Wiedemann R., Rose F., et al. Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann Intern Med 136 (2002) 515-522
12. Trachte A.L., Lobato E.B., Urdaneta F., et al. Oral sildenafil reduces pulmonary hypertension after cardiac surgery. Ann Thorac Surg 79 (2005) 194-197
13. Mychaskiw G., Sachdev V., and Heath B.J. Sildenafil (Viagra) facilitates weaning of inhaled nitric oxide following placement of a biventricular-assist device. J Clin Anesth 13 (2001) 218-220
14. Atz A.M., and Wessel D.L. Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 91 (1999) 307-310
15. Klodell C.T., Staples E.D., Aranda Jr. J.M., et al. Managing the post-left ventricular assist device patient. Congest Heart Fail 12 (2006) 41-45
16. Lobato E.B., Beaver T., Muehlschlegel J., et al. Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 96 (2006) 317-322
17. Galie N., Ghofrani H.A., Torbicki A., et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 353 (2005) 2148-2157
18. Haddad E., Lowson S.M., Johns R.A., and Rich G.F. Use of inhaled nitric oxide perioperatively and in intensive care patients. Anesthesiology 92 (2000) 1821-1825
19. Lepore J.J., Maroo A., Bigatello L.M., et al. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide. Chest 127 (2005) 1647-1653